245 related articles for article (PubMed ID: 25899160)
1. Fatal Intraperitoneal Bleeding after Intravenous Administration of Tissue Plasminogen Activator.
Anan C; Oomura M; Saeki T; Ikeda T; Sato C; Yamada K
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):e177-8. PubMed ID: 25899160
[TBL] [Abstract][Full Text] [Related]
2. Fatal multiple systemic emboli after intravenous thrombolysis for cardioembolic stroke.
Tanaka K; Ohara T; Ishigami A; Ikeda Y; Matsushige T; Satow T; Ishibashi-Ueda H; Iihara K; Toyoda K
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):395-7. PubMed ID: 23545321
[TBL] [Abstract][Full Text] [Related]
3. Catastrophic Secondary Infarctions with Onset Seizure Following Tissue Plasminogen Activator Therapy.
Matsuzono K; Nagaoka L; Suzuki M; Kim Y; Ozawa T; Mashiko T; Shimazaki H; Koide R; Fujimoto S
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):e24-e26. PubMed ID: 30655041
[TBL] [Abstract][Full Text] [Related]
4. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with rivaroxaban.
Ishihara H; Torii H; Imoto H; Oka F; Sadahiro H; Suzuki M
J Stroke Cerebrovasc Dis; 2014; 23(10):e457-e459. PubMed ID: 25280819
[TBL] [Abstract][Full Text] [Related]
5. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report.
Matsuzaki T; Yoshino A; Sakatani K; Katayama Y
J Stroke Cerebrovasc Dis; 2011; 20(3):269-72. PubMed ID: 20630773
[TBL] [Abstract][Full Text] [Related]
6. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
7. Successful intra-arterial thrombolysis in a patient with an intracranial meningioma.
Baiense RF; Abrahão A; Ricarte IF; Fukuda TG; Oliveira RA; Silva GS; Costa M; Teixeira MJ
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e658-60. PubMed ID: 23830958
[TBL] [Abstract][Full Text] [Related]
8. Myocardial Infarction Following Intravenous Thrombolysis for Acute Ischemic Stroke: Case Report and Literature Review.
Mannino M; Asciutto S; Terruso V; Gammino M; Cellura MG; Monaco S
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e105-e107. PubMed ID: 28434774
[TBL] [Abstract][Full Text] [Related]
9. Right internal carotid artery occlusion during intravenous thrombolysis for left middle cerebral artery occlusion.
Yalcin-Cakmakli G; Akpinar E; Topcuoglu MA; Dalkara T
J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):74-7. PubMed ID: 19110150
[TBL] [Abstract][Full Text] [Related]
10. Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry.
Miyagi T; Koga M; Shiokawa Y; Nakagawara J; Hasegawa Y; Furui E; Kimura K; Kario K; Okuda S; Yamagami H; Okada Y; Nezu T; Maeda K; Endo K; Minematsu K; Toyoda K
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1098-106. PubMed ID: 23063059
[TBL] [Abstract][Full Text] [Related]
11. [Thrombolysis by intravenous tissue plasminogen activator (t-PA)--current status and future direction].
Tanahashi N
Brain Nerve; 2009 Jan; 61(1):41-52. PubMed ID: 19177806
[TBL] [Abstract][Full Text] [Related]
12. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era.
Endo K; Koga M; Sakai N; Yamagami H; Furui E; Matsumoto Y; Shiokawa Y; Yoshimura S; Okada Y; Nakagawara J; Hyogo T; Hasegawa Y; Nagashima H; Fujinaka T; Hyodo A; Terada T; Toyoda K;
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):805-10. PubMed ID: 22721823
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Discrepancy between Measured versus Stated Weight on Hemorrhagic Transformation and Clinical Outcomes after Intravenous Alteplase Thrombolysis.
Shin DH; Kang MJ; Kim JW; Shin DJ; Park HM; Sung YH; Kim EY
Cerebrovasc Dis; 2017; 44(5-6):241-247. PubMed ID: 28848080
[TBL] [Abstract][Full Text] [Related]
14. Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.
Mendioroz M; Fernández-Cadenas I; Alvarez-Sabín J; Rosell A; Quiroga D; Cuadrado E; Delgado P; Rubiera M; Ribó M; Molina C; Montaner J
Cerebrovasc Dis; 2009; 28(2):143-50. PubMed ID: 19546541
[TBL] [Abstract][Full Text] [Related]
15. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
[TBL] [Abstract][Full Text] [Related]
16. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
17. Rectus Sheath Hematoma Following Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Cerebral Infarction: A Case Report.
Ueno T; Nakamura T; Hikichi H; Arai A; Suzuki C; Tomiyama M
J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):e237-e238. PubMed ID: 30122629
[TBL] [Abstract][Full Text] [Related]
18. Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.
Hirano T; Sasaki M; Tomura N; Ito Y; Kobayashi S;
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):898-902. PubMed ID: 21737309
[TBL] [Abstract][Full Text] [Related]
19. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT).
Yamaguchi T; Mori E; Minematsu K; Nakagawara J; Hashi K; Saito I; Shinohara Y;
Stroke; 2006 Jul; 37(7):1810-5. PubMed ID: 16763187
[TBL] [Abstract][Full Text] [Related]
20. Clinical deterioration following middle cerebral artery hemodynamic changes after intravenous thrombolysis for acute ischemic stroke.
Baizabal-Carvallo JF; Alonso-Juarez M; Samson Y
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):254-8. PubMed ID: 23433782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
